ID   ADK_HUMAN               Reviewed;         362 AA.
AC   P55263; B7Z783; B7Z800; O00741; O00742; Q16710; Q5JQ10; Q5JQ11;
AC   Q9BTN2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   15-MAR-2017, entry version 185.
DE   RecName: Full=Adenosine kinase;
DE            Short=AK;
DE            EC=2.7.1.20;
DE   AltName: Full=Adenosine 5'-phosphotransferase;
GN   Name=ADK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND PROTEIN SEQUENCE OF
RP   94-133; 175-200 AND 272-289.
RC   TISSUE=Liver;
RX   PubMed=8577746; DOI=10.1073/pnas.93.3.1232;
RA   Spychala J., Datta N.S., Takabayashi K., Datta M., Fox I.H.,
RA   Gribbin T., Mitchell B.S.;
RT   "Cloning of human adenosine kinase cDNA: sequence similarity to
RT   microbial ribokinases and fructokinases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:1232-1237(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RX   PubMed=8917457; DOI=10.1111/j.1432-1033.1996.00564.x;
RA   Singh B., Hao W., Wu Z.-C., Eigl B., Gupta R.S.;
RT   "Cloning and characterization of cDNA for adenosine kinase from
RT   mammalian (Chinese hamster, mouse, human and rat) species. High
RT   frequency mutants of Chinese hamster ovary cells involve structural
RT   alterations in the gene.";
RL   Eur. J. Biochem. 241:564-571(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=9070863; DOI=10.1006/bbrc.1997.6157;
RA   McNally T., Helfrich R.J., Cowart M., Dorwin S.A., Meuth J.L.,
RA   Idler K.B., Klute K.A., Simmer R.L., Kowaluk E.A., Halbert D.N.;
RT   "Cloning and expression of the adenosine kinase gene from rat and
RT   human tissues.";
RL   Biochem. Biophys. Res. Commun. 231:645-650(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4).
RC   TISSUE=Mammary gland, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   SUBCELLULAR LOCATION (ISOFORMS 1 AND 2), NUCLEAR LOCALIZATION SIGNAL,
RP   AND MUTAGENESIS OF 11-LYS-LYS-12.
RX   PubMed=19635462; DOI=10.1016/j.bbrc.2009.07.106;
RA   Cui X.A., Singh B., Park J., Gupta R.S.;
RT   "Subcellular localization of adenosine kinase in mammalian cells: The
RT   long isoform of AdK is localized in the nucleus.";
RL   Biochem. Biophys. Res. Commun. 388:46-50(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF ISOFORM 2.
RX   PubMed=9843365; DOI=10.1021/bi9815445;
RA   Mathews I.I., Erion M.D., Ealick S.E.;
RT   "Structure of human adenosine kinase at 1.5-A resolution.";
RL   Biochemistry 37:15607-15620(1998).
RN   [14]
RP   PHOSPHORYLATION AT TYR-77.
RX   PubMed=12112843;
RX   DOI=10.1002/1615-9861(200206)2:6<642::AID-PROT642>3.0.CO;2-I;
RA   Maguire P.B., Wynne K.J., Harney D.F., O'Donoghue N.M., Stephens G.,
RA   Fitzgerald D.J.;
RT   "Identification of the phosphotyrosine proteome from thrombin
RT   activated platelets.";
RL   Proteomics 2:642-648(2002).
RN   [15]
RP   VARIANTS HMAKD GLU-30; ALA-235 AND GLU-318, AND CHARACTERIZATION OF
RP   VARIANTS HMAKD GLU-30; ALA-235 AND GLU-318.
RX   PubMed=21963049; DOI=10.1016/j.ajhg.2011.09.004;
RA   Bjursell M.K., Blom H.J., Cayuela J.A., Engvall M.L., Lesko N.,
RA   Balasubramaniam S., Brandberg G., Halldin M., Falkenberg M.,
RA   Jakobs C., Smith D., Struys E., von Dobeln U., Gustafsson C.M.,
RA   Lundeberg J., Wedell A.;
RT   "Adenosine kinase deficiency disrupts the methionine cycle and causes
RT   hypermethioninemia, encephalopathy, and abnormal liver function.";
RL   Am. J. Hum. Genet. 89:507-515(2011).
CC   -!- FUNCTION: ATP dependent phosphorylation of adenosine and other
CC       related nucleoside analogs to monophosphate derivatives. Serves as
CC       a potential regulator of concentrations of extracellular adenosine
CC       and intracellular adenine nucleotides.
CC   -!- CATALYTIC ACTIVITY: ATP + adenosine = ADP + AMP.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 3 Mg(2+) ions per subunit.;
CC   -!- PATHWAY: Purine metabolism; AMP biosynthesis via salvage pathway;
CC       AMP from adenosine: step 1/1.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Nucleus
CC       {ECO:0000269|PubMed:19635462}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm
CC       {ECO:0000269|PubMed:19635462}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long;
CC         IsoId=P55263-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P55263-2; Sequence=VSP_046713;
CC       Name=3;
CC         IsoId=P55263-3; Sequence=VSP_043526;
CC       Name=4;
CC         IsoId=P55263-4; Sequence=VSP_004668;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highest level in placenta,
CC       liver, muscle and kidney.
CC   -!- DISEASE: Hypermethioninemia due to adenosine kinase deficiency
CC       (HMAKD) [MIM:614300]: A metabolic disorder characterized by global
CC       developmental delay, early-onset seizures, mild dysmorphic
CC       features, and characteristic biochemical anomalies, including
CC       persistent hypermethioninemia with increased levels of S-
CC       adenosylmethionine and S-adenosylhomocysteine. Homocysteine levels
CC       are typically normal. {ECO:0000269|PubMed:21963049}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the carbohydrate kinase PfkB family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB01689.1; Type=Frameshift; Positions=17; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U50196; AAA97893.1; -; mRNA.
DR   EMBL; U33936; AAB01689.1; ALT_FRAME; mRNA.
DR   EMBL; U90338; AAB50234.1; -; mRNA.
DR   EMBL; U90339; AAB50235.1; -; mRNA.
DR   EMBL; AK290633; BAF83322.1; -; mRNA.
DR   EMBL; AK301590; BAH13519.1; -; mRNA.
DR   EMBL; AK302706; BAH13786.1; -; mRNA.
DR   EMBL; AC012046; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022026; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022540; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091699; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357037; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL731576; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471083; EAW54555.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54556.1; -; Genomic_DNA.
DR   EMBL; BC003568; AAH03568.1; -; mRNA.
DR   CCDS; CCDS55716.1; -. [P55263-3]
DR   CCDS; CCDS55717.1; -. [P55263-4]
DR   CCDS; CCDS7343.1; -. [P55263-1]
DR   CCDS; CCDS7344.1; -. [P55263-2]
DR   PIR; JC5363; JC5363.
DR   PIR; JC5364; JC5364.
DR   RefSeq; NP_001114.2; NM_001123.3. [P55263-2]
DR   RefSeq; NP_001189378.1; NM_001202449.1. [P55263-4]
DR   RefSeq; NP_001189379.1; NM_001202450.1. [P55263-3]
DR   RefSeq; NP_006712.2; NM_006721.3. [P55263-1]
DR   UniGene; Hs.656586; -.
DR   PDB; 1BX4; X-ray; 1.50 A; A=22-362.
DR   PDB; 2I6A; X-ray; 2.20 A; A/B/C/D=22-362.
DR   PDB; 2I6B; X-ray; 2.30 A; A/B=22-362.
DR   PDB; 4O1L; X-ray; 2.50 A; A/B=17-362.
DR   PDBsum; 1BX4; -.
DR   PDBsum; 2I6A; -.
DR   PDBsum; 2I6B; -.
DR   PDBsum; 4O1L; -.
DR   ProteinModelPortal; P55263; -.
DR   SMR; P55263; -.
DR   BioGrid; 106644; 17.
DR   IntAct; P55263; 3.
DR   MINT; MINT-5001097; -.
DR   STRING; 9606.ENSP00000286621; -.
DR   BindingDB; P55263; -.
DR   ChEMBL; CHEMBL3589; -.
DR   DrugBank; DB07280; 5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE.
DR   DrugBank; DB01048; Abacavir.
DR   DrugBank; DB00640; Adenosine.
DR   DrugBank; DB00131; Adenosine monophosphate.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   DrugBank; DB00811; Ribavirin.
DR   GuidetoPHARMACOLOGY; 1231; -.
DR   iPTMnet; P55263; -.
DR   PhosphoSitePlus; P55263; -.
DR   SwissPalm; P55263; -.
DR   BioMuta; ADK; -.
DR   DMDM; 6840802; -.
DR   REPRODUCTION-2DPAGE; IPI00234368; -.
DR   EPD; P55263; -.
DR   MaxQB; P55263; -.
DR   PaxDb; P55263; -.
DR   PeptideAtlas; P55263; -.
DR   PRIDE; P55263; -.
DR   DNASU; 132; -.
DR   Ensembl; ENST00000286621; ENSP00000286621; ENSG00000156110. [P55263-1]
DR   Ensembl; ENST00000372734; ENSP00000361819; ENSG00000156110. [P55263-2]
DR   Ensembl; ENST00000539909; ENSP00000443965; ENSG00000156110. [P55263-3]
DR   Ensembl; ENST00000541550; ENSP00000438321; ENSG00000156110. [P55263-4]
DR   GeneID; 132; -.
DR   KEGG; hsa:132; -.
DR   UCSC; uc001jwi.4; human. [P55263-1]
DR   CTD; 132; -.
DR   DisGeNET; 132; -.
DR   GeneCards; ADK; -.
DR   HGNC; HGNC:257; ADK.
DR   HPA; CAB032876; -.
DR   HPA; HPA038391; -.
DR   HPA; HPA038409; -.
DR   MalaCards; ADK; -.
DR   MIM; 102750; gene.
DR   MIM; 614300; phenotype.
DR   neXtProt; NX_P55263; -.
DR   OpenTargets; ENSG00000156110; -.
DR   Orphanet; 289290; Hypermethioninemia encephalopathy due to adenosine kinase deficiency.
DR   PharmGKB; PA24579; -.
DR   eggNOG; KOG2854; Eukaryota.
DR   eggNOG; COG0524; LUCA.
DR   GeneTree; ENSGT00390000014320; -.
DR   HOGENOM; HOG000172419; -.
DR   HOVERGEN; HBG002367; -.
DR   InParanoid; P55263; -.
DR   KO; K00856; -.
DR   OMA; ISQFYMA; -.
DR   OrthoDB; EOG091G0JQC; -.
DR   PhylomeDB; P55263; -.
DR   TreeFam; TF300745; -.
DR   BioCyc; MetaCyc:HS08097-MONOMER; -.
DR   BRENDA; 2.7.1.20; 2681.
DR   Reactome; R-HSA-74217; Purine salvage.
DR   SABIO-RK; P55263; -.
DR   UniPathway; UPA00588; UER00659.
DR   ChiTaRS; ADK; human.
DR   EvolutionaryTrace; P55263; -.
DR   GeneWiki; ADK_(gene); -.
DR   GenomeRNAi; 132; -.
DR   PRO; PR:P55263; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000156110; -.
DR   CleanEx; HS_ADK; -.
DR   ExpressionAtlas; P55263; baseline and differential.
DR   Genevisible; P55263; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0004001; F:adenosine kinase activity; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006169; P:adenosine salvage; IBA:GO_Central.
DR   GO; GO:0044209; P:AMP salvage; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006175; P:dATP biosynthetic process; IEA:Ensembl.
DR   GO; GO:0043101; P:purine-containing compound salvage; TAS:Reactome.
DR   GO; GO:0009156; P:ribonucleoside monophosphate biosynthetic process; TAS:ProtInc.
DR   Gene3D; 3.40.1190.20; -; 1.
DR   InterPro; IPR001805; Adenokinase.
DR   InterPro; IPR002173; Carboh/pur_kinase_PfkB_CS.
DR   InterPro; IPR011611; PfkB_dom.
DR   InterPro; IPR029056; Ribokinase-like.
DR   PANTHER; PTHR10584:SF220; PTHR10584:SF220; 1.
DR   Pfam; PF00294; PfkB; 1.
DR   PRINTS; PR00989; ADENOKINASE.
DR   SUPFAM; SSF53613; SSF53613; 1.
DR   PROSITE; PS00584; PFKB_KINASES_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disease mutation; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Purine salvage;
KW   Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    362       Adenosine kinase.
FT                                /FTId=PRO_0000080053.
FT   MOTIF         8     16       Nuclear localization signal.
FT                                {ECO:0000269|PubMed:19635462}.
FT   ACT_SITE    317    317
FT   METAL        49     49       Magnesium 1.
FT   METAL       147    147       Magnesium 2.
FT   METAL       148    148       Magnesium 2.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      77     77       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:12112843}.
FT   VAR_SEQ       1     65       MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVD
FT                                KDFLDKYSLKPNDQILAEDKHKEL -> MTSVRENILFGMG
FT                                NPLLDISAVVDKDFLDK (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_004668.
FT   VAR_SEQ       1     21       MAAAEEEPKPKKLKVEAPQAL -> MTSV (in isoform
FT                                2). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8577746,
FT                                ECO:0000303|PubMed:9070863}.
FT                                /FTId=VSP_046713.
FT   VAR_SEQ     186    242       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043526.
FT   VARIANT      30     30       G -> E (in HMAKD; the mutant shows some
FT                                residual activity; dbSNP:rs397514454).
FT                                {ECO:0000269|PubMed:21963049}.
FT                                /FTId=VAR_066640.
FT   VARIANT     235    235       D -> A (in HMAKD; the mutant shows some
FT                                residual activity; dbSNP:rs397514453).
FT                                {ECO:0000269|PubMed:21963049}.
FT                                /FTId=VAR_066641.
FT   VARIANT     318    318       A -> E (in HMAKD; complete loss of
FT                                activity; dbSNP:rs397514452).
FT                                {ECO:0000269|PubMed:21963049}.
FT                                /FTId=VAR_066642.
FT   MUTAGEN      11     12       KK->AA,AD: Abolishes nuclear
FT                                localization.
FT                                {ECO:0000269|PubMed:19635462}.
FT   CONFLICT     98     98       H -> A (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    133    133       N -> D (in Ref. 2; AAB01689).
FT                                {ECO:0000305}.
FT   CONFLICT    171    171       K -> R (in Ref. 2; AAB01689).
FT                                {ECO:0000305}.
FT   CONFLICT    190    190       T -> H (in Ref. 1; AAA97893).
FT                                {ECO:0000305}.
FT   CONFLICT    219    219       I -> F (in Ref. 7; AAH03568).
FT                                {ECO:0000305}.
FT   CONFLICT    273    273       S -> V (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    289    289       I -> N (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    307    307       K -> R (in Ref. 2; AAB01689).
FT                                {ECO:0000305}.
FT   STRAND       26     29       {ECO:0000244|PDB:1BX4}.
FT   STRAND       33     39       {ECO:0000244|PDB:1BX4}.
FT   HELIX        42     47       {ECO:0000244|PDB:1BX4}.
FT   STRAND       52     57       {ECO:0000244|PDB:1BX4}.
FT   HELIX        60     62       {ECO:0000244|PDB:1BX4}.
FT   HELIX        63     72       {ECO:0000244|PDB:1BX4}.
FT   STRAND       76     80       {ECO:0000244|PDB:1BX4}.
FT   HELIX        82     94       {ECO:0000244|PDB:1BX4}.
FT   STRAND       96     99       {ECO:0000244|PDB:2I6B}.
FT   STRAND      101    110       {ECO:0000244|PDB:1BX4}.
FT   HELIX       111    122       {ECO:0000244|PDB:1BX4}.
FT   STRAND      126    135       {ECO:0000244|PDB:1BX4}.
FT   STRAND      139    145       {ECO:0000244|PDB:1BX4}.
FT   STRAND      148    154       {ECO:0000244|PDB:1BX4}.
FT   HELIX       156    160       {ECO:0000244|PDB:1BX4}.
FT   HELIX       163    165       {ECO:0000244|PDB:1BX4}.
FT   TURN        166    168       {ECO:0000244|PDB:1BX4}.
FT   HELIX       170    178       {ECO:0000244|PDB:1BX4}.
FT   STRAND      180    185       {ECO:0000244|PDB:1BX4}.
FT   HELIX       186    190       {ECO:0000244|PDB:1BX4}.
FT   HELIX       193    205       {ECO:0000244|PDB:1BX4}.
FT   STRAND      209    213       {ECO:0000244|PDB:1BX4}.
FT   HELIX       217    222       {ECO:0000244|PDB:1BX4}.
FT   HELIX       224    230       {ECO:0000244|PDB:1BX4}.
FT   HELIX       231    233       {ECO:0000244|PDB:1BX4}.
FT   STRAND      235    240       {ECO:0000244|PDB:1BX4}.
FT   HELIX       241    250       {ECO:0000244|PDB:1BX4}.
FT   HELIX       258    266       {ECO:0000244|PDB:1BX4}.
FT   STRAND      278    283       {ECO:0000244|PDB:1BX4}.
FT   STRAND      286    291       {ECO:0000244|PDB:1BX4}.
FT   STRAND      296    299       {ECO:0000244|PDB:1BX4}.
FT   HELIX       312    327       {ECO:0000244|PDB:1BX4}.
FT   TURN        328    330       {ECO:0000244|PDB:1BX4}.
FT   HELIX       333    347       {ECO:0000244|PDB:1BX4}.
FT   STRAND      350    353       {ECO:0000244|PDB:1BX4}.
SQ   SEQUENCE   362 AA;  40545 MW;  48AA4925865BFE70 CRC64;
     MAAAEEEPKP KKLKVEAPQA LRENILFGMG NPLLDISAVV DKDFLDKYSL KPNDQILAED
     KHKELFDELV KKFKVEYHAG GSTQNSIKVA QWMIQQPHKA ATFFGCIGID KFGEILKRKA
     AEAHVDAHYY EQNEQPTGTC AACITGDNRS LIANLAAANC YKKEKHLDLE KNWMLVEKAR
     VCYIAGFFLT VSPESVLKVA HHASENNRIF TLNLSAPFIS QFYKESLMKV MPYVDILFGN
     ETEAATFARE QGFETKDIKE IAKKTQALPK MNSKRQRIVI FTQGRDDTIM ATESEVTAFA
     VLDQDQKEII DTNGAGDAFV GGFLSQLVSD KPLTECIRAG HYAASIIIRR TGCTFPEKPD
     FH
//
